Improvement of ischemia-reperfusion-induced myocardial dysfunction by modulating calcium-overload using a novel, specific calmodulin antagonist, CGS 9343B.

[1]  M K Smith,et al.  Calcium/calmodulin-dependent protein kinase II. , 1989, The Biochemical journal.

[2]  R. Schatzman,et al.  Phospholipid-sensitive calcium-dependent protein kinase: inhibition by antipsychotic drugs. , 1981, Biochemical and biophysical research communications.

[3]  R. V. Vander Heide,et al.  Modification of caffeine-induced injury in Ca2+-free perfused rat hearts. Relationship to the calcium paradox. , 1986, The American journal of pathology.

[4]  W. Nayler,et al.  Fundamental mechanisms of action of calcium antagonists in myocardial ischemia. , 1987, The American journal of cardiology.

[5]  T. Soderling,et al.  Identification of membrane-bound calcium, calmodulin-dependent protein kinase II in canine heart. , 1987, Archives of biochemistry and biophysics.

[6]  R. Adelstein,et al.  Phosphorylation of phospholamban by calcium-activated, phospholipid-dependent protein kinase. Stimulation of cardiac sarcoplasmic reticulum calcium uptake. , 1984, The Journal of biological chemistry.

[7]  D. Das,et al.  Simultaneous quantification of myocardial adenine nucleotides and creatine phosphate by ion-pair reversed-phase high-performance liquid chromatography. , 1987, Journal of chromatography.

[8]  A. Katz,et al.  Cellular calcium and cardiac cell death. , 1979, The American journal of cardiology.

[9]  O. Scharff Calmodulin — And its role in cellular activation , 1981 .

[10]  S. Lemeshow,et al.  Role of membrane phospholipids in myocardial injury induced by ischemia and reperfusion. , 1986, The American journal of physiology.

[11]  Y. Nishizuka Phospholipid degradation and signal translation for protein phosphorylation , 1983 .

[12]  L. Wennogle,et al.  CGS 9343B, a novel, potent, and selective inhibitor of calmodulin activity. , 1987, Molecular pharmacology.

[13]  S. Lemeshow,et al.  Mepacrine, a phospholipase inhibitor. A potential tool for modifying myocardial reperfusion injury. , 1986, The Journal of thoracic and cardiovascular surgery.

[14]  W. Nayler,et al.  Contracture and the Calcium Paradox in the Rat Heart , 1987, Circulation research.

[15]  D. Maclennan,et al.  Calmidazolium and compound 48/80 inhibit calmodulin-dependent protein phosphorylation and ATP-dependent Ca2+ uptake but not Ca2+-ATPase activity in skeletal muscle sarcoplasmic reticulum. , 1984, The Journal of biological chemistry.

[16]  M. Hess,et al.  Calmodulin participation in oxygen radical-induced cardiac sarcoplasmic reticulum calcium uptake reduction. , 1987, Archives of biochemistry and biophysics.

[17]  K. J. Blackburn,et al.  Prevention of reperfusion damage in working rat hearts by calcium antagonists and calmodulin antagonists. , 1984, Journal of molecular and cellular cardiology.